JPRN-UMIN000024905
Completed
未知
A randomized, open-label, crossover study to evaluate ICS/LABA treatment versus LAMA/LABA treatment in COPD with eosinophilic inflammation - COPD and eosinophilic inflammation.
Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital0 sites25 target enrollmentNovember 21, 2016
ConditionsCOPD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- COPD
- Sponsor
- Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Asthma overlap (ACOS); history of lung resection; using inhaled or oral corticosteroid; receiving anti\-IgE therapy; and exacerbation of COPD in the 4 weeks.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An open-label, randomized crossover study to evaluate the pharmacokinetics, bioavailability, bioequivalence, and food effect following administration of Oxybate Formulations in healthy subjects.NL-OMON41817Jazz Pharmaceuticals60
Completed
Not Applicable
An open-label, randomized crossover study to evaluate the effect of ASP1941 on the pharmacokinetics, pharmacodynamics, safety and tolerability of glimepiride in healthy subjects and vice versa.NL-OMON34715Astellas Pharma26
Withdrawn
Not Applicable
An open-label, randomized, crossover study to evaluate the pharmacokinetics, bioavailability, and bioequivalence following administration of JZP-507 oral solution and Xyrem®in healthy subjects.cataplexynarcolepsy10040998NL-OMON45490Jazz Pharmaceuticals60
Active, not recruiting
Not Applicable
Patient preferences for Eucreas® versus Victoza® in Type 2 Diabetes mellitus patientstype 2 diabetes mellitusMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2011-003818-16-DEovartis Pharma GmbH
Completed
Not Applicable
Randomized, open-label, crossover study to evaluaute an effects of genetic polymorphism on pharmacokinetic & pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteersNot ApplicableKCT0000443Inje University Busan Paik Hospital27